Healius | HLS - Aktiva

Keuangan

AUD

AUD 3.07B

AUD 60.1M

Biaya Penjualan

AUD 218.7M

AUD 1.04B

Kewajiban Lancar

AUD 804.2M

AUD 1.4B

Dividen - Hasil

7.19

AUD 23.7M

AUD 74.9M

8K

Eps Laba Per Saham

AUD -0.04

Modal Dan Cadangan

AUD 1.03B

Laba Kotor Pada Penjualan

AUD 554.4M

Beban Bunga Utang

AUD 32.8M

AUD 1.22B

Kapitalisasi Pasar

AUD 308.59M

Batas Pemasukan

AUD -12.8M

Biaya Operasional

AUD 684.9M

Laba Operasional

AUD -22.6M

Modal Saham Biasa

AUD 2.6B

Pe Harga Untuk Laba

57.43

Laba Sebelum Pajak

AUD -19.2M

Pendapatan Penjualan

AUD 688.1M

Beban Penjualan Dan Administrasi

AUD 393.4M

AUD 31.9M

Kreditur Perdagangan

AUD 133.9M

Debitur Perdagangan

AUD 144.6M

	Aktiva	Perubahan		Tanggal
Alcidion	AUD 118.08M		2.46M	2025-12
Ansell	USD 3.33B		3.2M	2025-12
Cochlear	AUD 2.79B		31.3M	2025-12
CSL	USD 37.9B		1.5B	2025-12
Fisher Paykel Healthcare	NZD 2.85B		222.3M	2026-06
Integral Diagnostics	AUD 744.28M		1.52M	2024-06
Mayne Pharma	AUD 1.14B		9.47M	2024-06
Nanosonics	AUD 279.25M		6.77M	2025-12
Polynovo	AUD 123.37M		4.04M	2025-12
Ramsay Health Care	AUD 21.7B		777.8M	2025-12
ResMed	USD 8.78B		280.91M	2026-03
Sigma Healthcare	AUD 8.29B		6.91B	2025-12
Sonic Healthcare	AUD 15.38B		550.57M	2024-12